Kuppermann Miriam, Learman Lee A, Gates Elena, Gregorich Steven E, Nease Robert F, Lewis James, Washington A Eugene
Department of Obstetrics, University of California, San Francisco, California 94143-0856, USA.
Obstet Gynecol. 2006 May;107(5):1087-97. doi: 10.1097/01.AOG.0000214953.90248.db.
To identify predictors of prenatal genetic testing decisions and explore whether racial or ethnic and socioeconomic differences are explained by knowledge, attitudes, and preferences.
This was a prospective cohort study of 827 English-, Spanish-, or Chinese-speaking pregnant women presenting for care by 20 weeks of gestation at 1 of 23 San Francisco Bay-area obstetrics clinics and practices. Our primary outcome measure for women aged less than 35 years was any prenatal genetic testing use compared with none, and for women aged 35 years or older, prenatal testing strategy (no testing, screening test first, straight to invasive diagnostic testing). Baseline questionnaires were completed before any prenatal test use; test use was assessed after 30 gestational weeks.
Among women aged less than 35 years, no racial or ethnic differences in test use emerged. Multivariable analyses yielded three testing predictors: prenatal care site (P = .024), inclination to terminate pregnancy of a Down-syndrome-affected fetus (odds ratio 2.94, P = .002) and belief that modern medicine interferes too much in pregnancy (odds ratio .85, P = .036). Among women aged 35 years or older, observed racial or ethnic and socioeconomic differences in testing strategy were mediated by faith and fatalism, value of testing information, and perceived miscarriage risk. Multivariable predictors of testing strategy included these 3 mediators (P = .035, P < .001, P = .037, respectively) and health care system distrust (P = .045). A total of 29.5% of screen-positive women declined amniocentesis; 6.6% of women screening negative underwent amniocentesis.
Racial or ethnic and socioeconomic differences in prenatal testing strategy are mediated by risk perception and attitudes. Screening is not the best choice for many women. Optimal prenatal testing counseling requires clarification of risks and consideration of key attitudes and preferences regarding the possible sequence of events after testing decisions.
确定产前基因检测决策的预测因素,并探讨种族或民族以及社会经济差异是否可以通过知识、态度和偏好来解释。
这是一项前瞻性队列研究,研究对象为827名在旧金山湾区23家产科诊所和医疗机构中怀孕20周前来就诊的讲英语、西班牙语或中文的孕妇。我们针对年龄小于35岁女性的主要结局指标是是否使用产前基因检测(与未使用进行比较),对于年龄35岁及以上的女性,主要结局指标是产前检测策略(不检测、先进行筛查检测、直接进行侵入性诊断检测)。在首次使用任何产前检测之前完成基线问卷调查;在妊娠30周后评估检测使用情况。
在年龄小于35岁的女性中,检测使用方面未出现种族或民族差异。多变量分析得出三个检测预测因素:产前护理地点(P = 0.024)、终止唐氏综合征胎儿妊娠的倾向(比值比2.94,P = 0.002)以及认为现代医学对妊娠干预过多的信念(比值比0.85,P = 0.036)。在年龄35岁及以上的女性中,检测策略中观察到的种族或民族以及社会经济差异由信仰和宿命论、检测信息的价值以及感知到的流产风险介导。检测策略的多变量预测因素包括这三个介导因素(分别为P = 0.035、P < 0.001、P = 0.037)以及对医疗保健系统的不信任(P = 0.045)。共有29.5%的筛查阳性女性拒绝羊膜穿刺术;6.6%筛查阴性的女性接受了羊膜穿刺术。
产前检测策略中的种族或民族以及社会经济差异由风险感知和态度介导。筛查并非对许多女性的最佳选择。最佳的产前检测咨询需要明确风险,并考虑检测决策后可能发生的一系列事件的关键态度和偏好。